LM11A-31 |
| Catalog No.GC25581 |
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 289475-77-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
LM11A-31 is a small molecule p75NTR Ligand that reverses cholinergic neurite dystrophy in alzheimer's diseasemousemodels with mid- to late-stage disease progression.
LM11A-31 greatly reduces or eliminates the neuronal pathology as well as the FIV effects on astrocytes and microglia in an infectious in vitro model, indicating an excellent potential for the treatment of HIV-associated neurodegeneration.[1]
LM11A-31 is a small molecular p75NTR ligand, which reverses cholinergic neurite dystrophy in mice with advanced Alzheimer's disease.[2]
[1] Meeker RB, et al. J Neuroimmune Pharmacol. 2012 Jun;7(2):388-400. "[2] Danielle A Simmons, et al. PLoS One . 2014 Aug 25;9(8):e102136.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *